GSK plc (GSK) ORD GBP0.3125

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
London close: Stocks little changed after UK data dump
21 February 2025 15:46
(Sharecast News) - London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing private sector growth.
-
GSK seen as potential target for activist investors
21 February 2025 11:54
(Sharecast News) - Drugmaker GSK has been tapped as a potential target for activist investors, according to Bloomberg, which noted that shares had fallen roughly 19% since spinning off its consumer health...
-
London close: Stocks slip as US jobless claims rise
20 February 2025 16:06
(Sharecast News) - London equities ended lower on Thursday as investors reacted to a higher-than-expected rise in US jobless claims and a decline in UK consumer confidence.
-
GSK 5-in1 meningitis drug gets US approval
17 February 2025 07:04
(Sharecast News) - GSK said the US Food and Drug Administration has approved its Penmenvy drug to treat meningitis for use in individuals aged10 - 25 years.
-
GSK ups five-year sales outlook, unveils $2bn buyback
5 February 2025 07:19
(Sharecast News) - GSK's annual revenues were held back weak vaccines sales, but shares in the pharma giant jumped on Wednesday after the company unveiled plans to buy back £2bn of stock over the next...
-
GSK's pre-filled shingles vaccine accepted for review by EMA
27 January 2025 07:08
(Sharecast News) - GSK has announced that a pre-filled syringe version of its Shingrix shingles vaccine has been accepted for review by the European Medicines Agency.
-
EU regulators expand usage of GSK's Jemperli cancer drug
20 January 2025 07:22
(Sharecast News) - European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced on Monday.
-
Pfizer pares back Haleon stake in £2.5bn sale
15 January 2025 08:10
(Sharecast News) - Pfizer has further reduced its holding in Haleon, it was confirmed on Wednesday, after the drugs giant offloaded 700m shares in a £2.5bn sale.
-
London close: Stocks fall, pound weakens further on rising bond yields
13 January 2025 15:19
(Sharecast News) - London stocks ended Monday in negative territory, pressured by rising bond yields and diminished expectations for near-term interest rate cuts.
-
GSK application for new Shingrix formulation accepted by FDA
10 January 2025 07:23
(Sharecast News) - GSK announced on Friday that the US Food and Drug Administration (FDA) has accepted its regulatory application for a prefilled syringe version of Shingrix, its recombinant zoster vaccine...
-
GSK cancer drug candidate gets another breakthrough designation
7 January 2025 07:22
(Sharecast News) - GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy designation by the US Food and Drug Administration (FDA) for...
-
London close: Stocks finish first week of 2025 weaker
3 January 2025 17:12
(Sharecast News) - London stock markets closed in the red on Friday as sharp declines in airline, mining, and housebuilding stocks weighed on indices, with a lack of significant news and profit-taking...
Company announcements Announcements
-
Directorate Change
21 February 2025 07:00
GSK
-
Director/PDMR Shareholding
21 February 2025 07:00
GSK
-
Director/PDMR Shareholding
21 February 2025 07:00
GSK
-
Director/PDMR Shareholding
21 February 2025 07:00
GSK
-
Director/PDMR Shareholding
21 February 2025 07:00
GSK
-
Director/PDMR Shareholding
21 February 2025 07:00
GSK
-
Director/PDMR Shareholding
21 February 2025 07:00
GSK
-
Nucala COPD submission accepted in China
20 February 2025 07:00
GSK
-
GSK 5-in-1 meningitis vaccine approved by US FDA
17 February 2025 07:00
GSK
-
Director/PDMR Shareholding
13 February 2025 15:30
GSK
-
Director/PDMR Shareholding
11 February 2025 15:30
GSK
-
Final Results
5 February 2025 07:00
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.